Stockhub

Immuron Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 August 2022

  • curprev 12:4612:46, 19 August 2022 >Nick 1,376 bytes +1,376 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Immuron Limited, a biopharmaceutical company, researches, develops, and commercializes polyclonal antibodies in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It markets Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and reduce the symptoms of minor gastro-intestinal disorders, as well as for..."
Retrieved from "https://stockhub.co/research/Immuron_Limited"